SR-9009 Stenabolic Capsules

Buy SR-9009 Stenabolic Capsules Online

SR-9009, commonly known as Stenabolic, is a synthetic small-molecule REV-ERB agonist studied primarily in preclinical research. It has attracted attention for its effects on circadian regulation, metabolism, inflammation, and exercise-related pathways.

Product Information

SR-9009 activates REV-ERBα/β, nuclear receptors involved in the molecular circadian clock and metabolic regulation. Research has investigated the compound in animal models of metabolism, inflammation, cardiovascular disease, and neurological conditions. SR-9009 is also known as Stenabolic and is a synthetic REV-ERB agonist.

How It Works

SR-9009 activates REV-ERB receptors that regulate genes involved in circadian rhythm and metabolism. This can alter downstream pathways controlling energy use, lipid metabolism, and inflammatory signaling.

POTENTIAL BENEFITS

1. Circadian-Rhythm Research

REV-ERB proteins are central components of the molecular clock, making SR-9009 a useful tool for investigating how circadian timing influences physiology.

2. Metabolic Research

Animal studies have linked REV-ERB activation with changes in lipid and glucose metabolism, making SR-9009 relevant to metabolic pathway research.

3. Exercise-Pathway Research

Preclinical studies have reported effects on exercise tolerance and skeletal-muscle metabolism, providing a basis for continued investigation of REV-ERB signaling in physical performance.

4. Inflammation Research

SR-9009 has demonstrated anti-inflammatory effects in several animal and cellular models, including pathways involving NLRP3 and NF-κB signaling.

Dosage

There is no established human dosage for SR-9009. Published dosing data are overwhelmingly preclinical; for example, animal studies have used doses such as 100 mg/kg under specific experimental conditions. Such doses cannot be converted into a validated human regimen.

Side Effects

Human safety data are extremely limited. Because REV-ERB signaling regulates multiple circadian and metabolic processes, unintended effects on sleep, metabolism, endocrine function, and cellular signaling remain important considerations.

References

1. PubMed — SR9009 and REV-ERB pharmacology
2. Li et al. — SR9009 analogues, exercise tolerance and glycolipid metabolism. PMID: 39059249
3. PubMed — SR9009 and inflammation
4. PubMed — SR9009 and metabolic research

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.